本报讯 （记者王镜茹）2025年，广东泰恩康医药股份有限公司（以下简称"泰恩康"）秉持"以投资者为本"的核心理念，扎 实推进信息披露、公司治理、市值管理、社会责任等各项工作，以专业高效的履职成效筑牢泰恩康的合规经营根基，推动企业 价值稳步提升。 与此同时，泰恩康在资本市场及行业领域捷报频传，凭借在创新研发、市值管理、公司治理、ESG实践等多维度的卓越表 现，斩获多项权威大奖；董事、副总经理兼董事会秘书李挺亦荣膺多项个人殊荣，彰显泰恩康高质量发展所获得的广泛市场认 可。 2025年泰恩康以精准的信息披露、高效的治理体系、创新的市值管理及扎实的ESG实践，为公司高质量发展筑牢根基。未 来，将继续深化投资者沟通、优化资本运作策略，助力泰恩康在医药创新赛道持续领跑，为股东创造长期价值，为资本市场健 康发展贡献更多力量。 （编辑 张昕） 值得关注的是，泰恩康于2025年12月15日被纳入中证1000指数拟生效样本范围。在业内人士看来，泰恩康被纳入中证1000 指数，不仅体现了公司基本面稳健经营与市场流动性良好，也标志着其投资价值获得指数编制机构的权威认可；同时，泰恩康 有望纳入相关ETF的被动配置范畴，从而为股价带来进 ...

同日，怀柔区发布了第一批"机遇清单"，清单包括45项可转化的科研技术成果、26项多元合作机会、10 处优质产业空间、17个已开放共享的科学设施平台、19只专项基金资源。据介绍，企业可通过"怀柔区 营商环境"小程序实时查阅，并通过线上智慧服务、线下专人对接的方式，便捷享受从技术、空间到资 本的全链条服务。大会还举行了重大项目集中签约仪式，10个项目成功签约，签约项目聚焦科技服务、 医药健康、科学智能、新能源四大前沿领域，涵盖共建医药健康科技项目高标准评审中心、超算互联网 枢纽节点、科研数据语料库、低空云平台、先进低温技术创新平台、国际科技成果转化平台等。 当日举行的揭牌活动中，7个重量级科技创新平台正式落地怀柔科学城，并将陆续投入运行。其中包括 细胞治疗与修复再生、原子制造与真空高端装备、具身智能计算、含碳资源转化、科学数据技术与系统 等五个北京市重点实验室。建设主体涵盖中国科学院大学、中国科学院物理研究所、中国科学院计算机 网络信息中心、北京干细胞与再生医学研究院等科研单位，以及中国医药、中科合成油技术等科技领军 企业。 新京报讯(记者周怀宗)1月4日，记者在北京市怀柔区2026年优化营商环境暨高质量发展推进 ...

经审议，董事会同意由LIUJUN（刘军）、孙茂松、赵宏担任AI医药专家委员会委员，其中LIUJUN （刘军）担任主任委员，3位委员的任期均为自本次董事会审议通过之日起至第六届董事会届满之日 止。 近日，华兰股份（301093）发布公告称，为适应公司战略发展需要，建立健全公司投资决策程序，完善 公司治理结构，增强公司决策科学性和核心竞争力，公司设立AI医药专家委员会。 ...

Group 1 - The article discusses the details of a military operation by the U.S. to capture Venezuelan President Maduro and his wife, with Trump stating that the U.S. will "manage" Venezuela until a "safe" transition occurs [2][5][3] - The operation involved over 150 aircraft and lasted approximately 2 hours and 20 minutes, with one aircraft being hit but still operational [5][6] - Trump indicated that if necessary, the U.S. would conduct a "larger" second wave of strikes against Venezuela, although he suggested that this may not be needed at the moment [6] Group 2 - BMW China announced price adjustments for 31 models, with reductions exceeding 10% for 24 models and over 20% for 5 models, with the highest drop being 301,000 yuan for the i7 M70L [6] - Xiaomi refuted claims regarding the alleged "fake" zoom ring on the 17 Ultra Leica version, stating that the accusations were misleading and based on misinterpretations of a teardown video [4][8] - NIO's CEO Li Bin announced that the company plans to launch three new models in 2026, aiming to increase its market share in the high-end vehicle segment [8] Group 3 - The price of 25-year-old Flying Moutai has dropped to 1,495 yuan per bottle, reflecting a decrease of 15 yuan from the previous day [9] - Tesla's global vehicle deliveries for 2025 were reported at 1.636 million, marking an 8.6% decline year-over-year, and for the first time, being surpassed by BYD in annual electric vehicle sales [9] - China's National Medical Products Administration reported that 76 innovative drugs were approved in 2025, significantly surpassing the 48 approved in 2024, with a total authorization value exceeding 130 billion USD [11]

县计县策 武陟县的高质量发展，既体现在工业与配套的硬实力上，又彰显于文旅融合、园区提质、营商环境优化 的软实力提升中。 武陟县坚持突出工业强县、创新驱动不动摇，以项目为支撑，深入推进"325"产业计划，大力实施主导 产业转型升级、主攻方向提升、科技创新和产业创新深度融合、文旅融合发展、产业园区能级提升"五 大行动"，加快构建具有武陟特色的现代化产业体系，为县域经济持续高质量发展注入不竭动力。 1月2日，在位于武陟经开区的河南大指造纸装备集成工程有限公司车间内，一台宽达8600毫米的高速造 纸机正进行精度调试，不久后将发往东南亚市场。 "我们聚力攻克宽幅高速造纸装备关键技术，推动成套装备国产化。"公司研发中心主任盛海鹏的话语， 正是武陟县以科技创新夯实实体经济、推动产业升级的生动缩影。 作为郑州都市圈特别合作区，武陟县坚持工业强县，聚焦焦作市"3+13+N"产业链群建设，深耕"325"产 业计划，打造都市圈重要产业配套区和生活服务区。 动能转换是产业升级的核心。该县以设备更新和技术升级为抓手，推动工业转型项目落地见效，实现规 上制造企业智能应用场景全覆盖。 项目建设夯实发展硬支撑。大指装备年产66台（套）造纸设 ...

营商环境是企业生存发展的土壤，好的营商环境就是生产力、竞争力。 习近平总书记高度重视优化营商环境，2024年10月在福建考察时要求，"营造更加完善的创新环境、更 有吸引力的人才环境""坚持'两个毫不动摇'，创新发展'晋江经验'，充分激发全社会投资创业活力"。 在2025年2月17日召开的民营企业座谈会上，习近平总书记对如何优化营商环境提出了明确要求，体现 出鲜明的问题导向。 福建深入贯彻落实习近平总书记关于优化营商环境的重要论述和对福建工作的重要要求，深入实施新时 代民营经济强省战略，创新发展"晋江经验"，持续打造市场化、法治化、国际化、便利化一流营商环 境。 连续5年召开民营经济代表人士座谈会，召开全省优化营商环境大会，编制实施福建省首份营商环境建 设规划，出台优化营商环境条例、营商环境创新改革行动计划，营商环境总体满意率连续4年超85%， 一体化政务服务能力连续2年位列全国第一梯队……高位推动、系统推进，福建正驰而不息打造一方近 悦远来的营商沃土，切实担起经济大省挑大梁的重大责任、勇争推动高质量发展之先。 知势谋远 驰而不息培优营商土壤 去年1月，全省首单民营企业公募REITs——易方达华威市场REIT在 ...

Group 1 - The core product of Sanfu Shipbuilding is a 10,000-ton multi-purpose heavy-lift vessel, which holds a 30% global market share. The company plans to deliver 41 vessels by 2025, including 10 of these heavy-lift ships, with projected sales of 5.5 billion yuan, representing a year-on-year growth of over 20%. The order backlog extends to 2029 [1][1][1] - The port industrial park in Taizhou has transitioned from a logistics focus to a port industry focus, aiming to attract projects and strengthen advanced manufacturing. This change is part of a broader strategy to enhance the park's industrial positioning and promote high-quality development [1][1][1] - The port industrial park has signed 25 projects worth over 100 million yuan, including 13 major projects exceeding 500 million yuan, such as a 2.5 billion yuan high-end ship supporting equipment project and a 1 billion yuan green ship production line upgrade [1][1][1] Group 2 - Taizhou is building a modern industrial system marked by "Dahai New Morning," focusing on optimizing traditional industries and fostering emerging sectors. The port industrial park is leveraging local enterprises to strengthen its leading industries, including marine, health, and precision manufacturing [2][2][2] - Tianming Precision Technology Co., Ltd. has achieved rapid growth, with a projected sales increase of 100% by 2025, supported by partnerships with major domestic electric vehicle companies. The company currently has an order backlog of 130 million yuan [2][2][2] - The health industry is a key sector for Taizhou, with plans for a 4.64 square kilometer pharmaceutical raw material production base to attract various projects. The region is also transforming its grain and oil industry into a high-value health food economy [2][2][2] Group 3 - The port industrial park has 2.2 kilometers of undeveloped deep-water coastline and 3,000 acres of contiguous land, suitable for six 100,000-ton berths, making it an ideal location for heavy equipment manufacturing projects [3][3][3] - The park aims to focus on the assembly and system integration of oversized and heavy equipment, such as offshore wind power components and large port machinery, to attract leading domestic and international companies to establish assembly bases [3][3][3]

每经编辑｜何小桃 陈鹏程 王晓波 标题点睛： 美股三大指数收盘涨跌不一，纳指高开低走，收跌0.03%，标普500指数微涨0.19%，道指涨0.66%。纳斯达克中国金龙指数涨4.38%，迎来"开门红"，中概 股普涨，百度收涨15%，哔哩哔哩、网易涨超7%，阿里巴巴涨超6%，京东涨近3%。 1月2日，"最快女护士"张水华在社交账号宣布辞职，"我辞去了陪伴多年的工作，特别感谢医院的培养，领导的信任，还有同事们的包容与支持，非常感 谢这段时间大家对我的批评与建议，这些都会成为我人生中最宝贵的财富，真心祝愿大家越来越好。" 1月2日晚间，《每日经济新闻》记者独家获悉，近日，宗馥莉重新担任宏胜饮料集团有限公司（以下简称宏胜集团）法定代表人。全国工商信息系统显 示，2025年12月26日，宏胜集团法定代表人由郑群娣变更为宗馥莉。 1 隔夜市场 美股三大指数收盘涨跌不一，纳指高开低走，收跌0.03%，标普500指数微涨0.19%，道指涨0.66%；明星科技股表现分化，阿斯麦涨超近9%，美光科技 涨超10%，二者股价均创历史新高；AMD涨超4%，英伟达涨超1%，谷歌微涨；特斯拉、微软跌超2%，亚马逊跌近2%，Meta跌超1%， ...

Core Viewpoint - In 2025, the pharmaceutical sector in the A-share market is actively engaging in stock buybacks, with many companies opting to destroy the repurchased shares, contrasting with the more subdued actions in the liquor sector [1][10]. Group 1: Buyback Activities - A total of 38 leading pharmaceutical companies participated in stock buybacks, with 6 companies spending over 500 million yuan, and the largest spending 1 billion yuan [1][3]. - WuXi AppTec, a major player in the pharmaceutical outsourcing industry, announced a buyback plan of 1 billion yuan, completing 497 million yuan by April 2025 [2][5]. - Hengrui Medicine, a leader in innovative drugs, announced a buyback plan of 2 billion yuan, having already repurchased 535 million yuan worth of shares by August 2025 [3][6]. - Other notable companies include Jingxin Pharmaceutical, which planned to spend 700 million yuan and has already spent 609 million yuan, and several others like New Harmony, Jiuzan Medical, and Nengte Technology, each spending over 500 million yuan [3][9]. Group 2: Purpose and Impact of Buybacks - The primary purpose of these buybacks is to cancel the repurchased shares, effectively reducing the total share capital and increasing the value of remaining shares for shareholders [4][10]. - This strategy is viewed as a strong signal of management's confidence in the company's future, especially during periods of low market sentiment [5][10]. - The buyback actions are seen as a more tangible commitment to shareholder value compared to merely announcing intentions to stabilize stock prices [4][10]. Group 3: Financial Health and Market Position - The companies engaging in these buybacks, such as WuXi AppTec and Hengrui Medicine, possess strong market positions and cash flows, allowing them to undertake such financial maneuvers [6][10]. - The buyback trend is not as prevalent in the liquor sector, indicating a potential difference in financial strategies and market confidence between the two industries [6][10]. - The buyback prices set by companies reflect a calculated approach, ensuring that they are responsible with shareholder funds [8][10].

上市公司：国药现代（600420），昆药集团（600422），片仔癀（600436），千金药业（600479），津 药药业（600488），国药股份（600511），联环药业（600513），合富中国（603122），康惠制药 （603139），莎普爱思（603168），奥翔药业（603229），大参林（603233） 相关报告：智研咨询发布的《2026-2032年中国医药制造外包（CMO/CDMO）行业市场发展态势及未来 趋势研判报告》 根据国家统计局数据可知：2025年11月全国医药制造业出口货值为189.7亿元，同比增长1.6%；2025年 1-11月全国医药制造业累计出口货值为2140.6亿元，累计同比增长11.7%。 2019年-2025年1-11月全国医药制造业出口货值统计图 数据来源：国家统计局，智研咨询整理 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 ...